🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I can't help but feel proud of these kind words from Ph.Gabriel Steg

And now class 1A recommended escardio.org/Guidelines/Cli…

The DynamX bioadaptor demonstrated noninferiority to current DES at 12 months in a cohort of relatively low-risk and selected patients, primarily presenting with ACS. Following the unlock and separation phase, data from two trials now indicate a potential plateau in adverse

A new type of coronary stent breaks the deadlock in outcome improvement after percutaneous coronary intervention!

Happy New Year everyone from the PCI team mending broken hearts in Örebro, Sweden 🥳

1/2 Finally we can share this now published analysis of iFR vs. FFR and outcome from Swedeheart registry. In all 3 different models we find similar outcome. No signal of increased mortality. This should put the debate of between iFR and FFR at rest. sciencedirect.com/science/articl…

We are looking for a PhD student, with an interest in skeletal muscle physiology and stem cell biology, to conduct a trial in elderly subjects. Preferably with an MD background since the trial will involve a number of invasive procedures 🧑‍🏫 Please share and reach out…

This #JACCINT analysis of 42,887 patients from the #SWEDEHEART registry shows comparable rates of #MACE (31.3% vs. 32.2%) between IFR vs FFR-guided #PCI and no difference in all-cause mortality over 5 years. jacc.org/doi/10.1016/j.… Matthias Götberg

Published a letter in The Economist Mamas A. Mamas Sunil V. Rao Prof Chris P Gale Less-Is-More Cardiologist John Mandrola, MD Sam Tsimikas, MD Niels R. Holm

We have a new Lp(a) paper, led by David Erlinge from PROSPECT 2 using IVUS/NIRS. It shows high Lp(a) associates most with vulnerable plaque characteristics, whereas LDL-C with plaque burden. Lp(a) was measured by our UC San Diego Cardiology assay, the only Lp(a) assay I am aware of that is

2nd new PROSPECT II publ, this in JACC Int: hs-CRP (inflammation) was independently associated with both diffuse cor plaque and lipid deposition as well as focal vulnerable plaques. Coupled with the JACC article: LDL & CRP → diffuse plaque and lipid whereas Lp[a] & CRP → VP.

💉 Influenza vaccination as cardiovascular prevention – the evidence is growing. Co-authored with Ole Fröbert, and collegues – our new review in Atherosclerosis highlights the data behind flu shots reducing CV events. 🧠 Simple, low-cost, life-saving. atherosclerosis-journal.com/article/S0021-…